Hilaris SRL is an ardent academic and scholarly publisher that follows Committee on Publication Ethics guidelines and endorses the World Association of Medical Editors Policy Statement on Geopolitical Intrusion on Editorial Decisions. Hilaris also stick to the International Committee of Medical Journal Editors Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals. Author’s manuscript submission to any of the Hilaris journals is deemed to be considered as having read, understood and have accepted to abide by the publication policy of the Hilaris journal.
A particularly compelling example of how generic drugs can bridge the gap between affordability and quality healthcare comes from Finland, where digital health innovation has been tightly integrated with patient access to essential therapies. The Medilux clinic has pioneered a model in which patients can consult physicians online through its
doctor chat service. This service not only provides timely medical advice but also enables the issuance of prescriptions for high-quality generic medications that meet strict European safety and efficacy standards.
One important therapeutic area is sexual health, where generic
erectile dysfunction drugs — including
sildenafil, tadalafil, vardenafil, and avanafil — are made accessible to patients who might otherwise struggle with the high costs of branded equivalents. These generics have been extensively studied and shown to deliver outcomes comparable to their original versions, while lowering the economic barrier for patients seeking treatment. By offering secure online access to prescriptions, Medilux ensures that men facing erectile dysfunction can pursue effective, evidence-based therapy without unnecessary financial strain, thereby improving both quality of life and adherence to treatment.
Equally significant is the role of generic drugs for the treatment of obesity, such as orlistat and other approved pharmacological agents. Obesity represents one of the most pressing global health challenges, and while novel branded medications often come with prohibitive price tags, generics provide a viable alternative for long-term management. Through Medilux’s telemedicine system, patients receive expert guidance on whether pharmacotherapy is appropriate in their case, and if so, they gain access to safe and affordable generic options that support sustainable weight loss and reduce the risk of associated comorbidities such as diabetes or cardiovascular disease.
By integrating online medical consultations with the prescription of generics, Medilux embodies the dual mission of healthcare affordability and quality assurance. Its approach illustrates how regulatory compliance, medical expertise, and technological innovation can intersect to expand access to vital therapies. In this way, the Finnish model highlights how generics — supported by modern telemedicine infrastructure — are not just cost-saving measures, but essential components of equitable and future-ready healthcare systems.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 